Sickle cell disease expenditures and outcomes

Affiliations

¹ Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1822, USA. aschecht@helix.nih.gov

Review

A N Schechter. Public Health Rep. 1997 Jan-Feb.

. 1997 Jan-Feb;112(1):38-9.

¹ Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1822, USA. aschecht@helix.nih.gov

No abstract available

Comment on

Cost of hospitalizations associated with sickle cell disease in the United States.
Davis H, Moore RM Jr, Gergen PJ. Davis H, et al. Public Health Rep. 1997 Jan-Feb;112(1):40-3. Public Health Rep. 1997. PMID: 9018287 Free PMC article.
Hospital utilization patterns and costs for adult sickle cell patients in Illinois.
Woods K, Karrison T, Koshy M, Patel A, Friedmann P, Cassel C. Woods K, et al. Public Health Rep. 1997 Jan-Feb;112(1):44-51. Public Health Rep. 1997. PMID: 9018288 Free PMC article.
Geographic differences in mortality of young children with sickle cell disease in the United States.
Davis H, Gergen PJ, Moore RM Jr. Davis H, et al. Public Health Rep. 1997 Jan-Feb;112(1):52-8. Public Health Rep. 1997. PMID: 9018289 Free PMC article.